{"id":101002,"date":"2024-05-13T13:38:00","date_gmt":"2024-05-13T11:38:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=101002"},"modified":"2024-07-09T16:48:08","modified_gmt":"2024-07-09T14:48:08","slug":"insempra-series-a","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/101002\/insempra-series-a\/","title":{"rendered":"Series A financing: Insempra receives 18.6 million euros"},"content":{"rendered":"<div class=\"entry-content\">\n<p>Insempra develops bio-based and biodegradable synthetic ingredients, materials, and fibers. The startup aims to offer sustainable alternatives to materials previously produced primarily from agricultural or petrochemical sources, as their production is often associated with environmental pollution and the exploitation of natural resources. For example, Insempra&#039;s Biotreasure team uses a special yeast to produce materials such as polyester and polyamide from plant residues, used cooking oil, or PET waste. This development is also being supported by a <a href=\"\/en\/95964\/sprind-funding-for-two-munich-biotech-startups\/\">Sprind promotion<\/a> Insempra already has functional ingredients such as flavors and fragrances on the market.<\/p>\n\n\n\n<p>Now <a href=\"\/en\/day\/together-2\/\">the startup<\/a> successfully completed its Series A financing round, raising \u20ac18.6 million ($20 million). The financing was led by existing investor EQT Ventures. Other investors include Bayern Kapital, Henkel dx Ventures, and Alante Capital. Existing investors BlueYard Capital, Possible Ventures, Taavet Sten, and Acequia Capital also participated in the round. The startup plans to use the new funding to further advance the development and market launch of its products.<\/p>\n\n\n\n<p><strong>Jens Klein<\/strong>, founder and CEO of Insempra, explains:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&quot;We are grateful for the support of our investors, who immediately recognized the potential of our market-leading processes and innovative technology platform. Our goal is to further expand our capabilities to develop sustainable, high-quality materials that help reduce manufacturing companies&#039; dependence on chemical, industrial materials.&quot;<\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">EQT Ventures: Insempra will drive \u201ca revolution in industrial manufacturing\u201d<\/h2>\n\n\n\n<p><strong>Ted Persson<\/strong>, Partner at <a href=\"https:\/\/eqtventures.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">EQT Ventures<\/a>, adds:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&quot;Insempra has both the team and the technology to drive a revolution in industrial manufacturing and achieve rapid market penetration for its products. New technology platforms like Insempra&#039;s have the potential to dramatically transform the manufacturing processes of multiple multi-billion dollar industries and develop tailored ingredients to meet market needs.&quot;<\/p>\n<\/blockquote>\n\n\n\n<p>And <strong>Monika Steger<\/strong>, Managing Director of Bayern Kapital, says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&quot;Global awareness of how we extract and use resources has changed. Consumers and end customers are increasingly demanding sustainability and climate protection, politicians are tightening the regulatory framework, and companies must adapt as a result. Manufacturers in all sectors, from cosmetics, fashion, and personal care to food, are therefore looking for sustainable alternatives for the basic materials and ingredients in their products. Insempra can develop precisely such sustainable production methods. The scaling potential of this innovative technology is enormous. That&#039;s why we are happy to support Insempra in its growth.&quot;<\/p>\n<\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Munich-based biotech company Insempra successfully raises \u20ac18.6 million in its Series A round. The financing is led by EQT Ventures, with additional investors including Bayern Kapital, Henkel dx Ventures, and Alante Capital.<\/p>","protected":false},"author":33,"featured_media":101003,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[52,4677],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Insempra erh\u00e4lt 18,6 Millionen Euro in Series-A - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Biotech Insempra sammelt in seiner Series-A-Runde erfolgreich 18,6 Millionen Euro ein. Die Finanzierung wird von EQT Ventures angef\u00fchrt.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/101002\/insempra-series-a\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insempra erh\u00e4lt 18,6 Millionen Euro in Series-A - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Biotech Insempra sammelt in seiner Series-A-Runde erfolgreich 18,6 Millionen Euro ein. Die Finanzierung wird von EQT Ventures angef\u00fchrt.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/101002\/insempra-series-a\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-13T11:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-09T14:48:08+00:00\" \/>\n<meta name=\"author\" content=\"Maximilian Feigl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maximilian Feigl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/\",\"url\":\"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/\",\"name\":\"Insempra erh\u00e4lt 18,6 Millionen Euro in Series-A - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/Insempra_Products.jpg\",\"datePublished\":\"2024-05-13T11:38:00+00:00\",\"dateModified\":\"2024-07-09T14:48:08+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\"},\"description\":\"Das M\u00fcnchner Biotech Insempra sammelt in seiner Series-A-Runde erfolgreich 18,6 Millionen Euro ein. Die Finanzierung wird von EQT Ventures angef\u00fchrt.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/Insempra_Products.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/Insempra_Products.jpg\",\"width\":2400,\"height\":1333,\"caption\":\"Insempra\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Series-A-Finanzierung: Insempra erh\u00e4lt 18,6 Millionen Euro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\",\"name\":\"Maximilian Feigl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"caption\":\"Maximilian Feigl\"},\"description\":\"Maximilian Feigl berichtet seit 2020 \u00fcber das M\u00fcnchner Startup \u00d6kosystem. Dabei haben es dem studierten Politikwissenschaftler vor allem Deeptech-Themen angetan.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2024\/05\/Insempra_Products.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insempra receives \u20ac18.6 million in Series A - Munich Startup","description":"Munich-based biotech company Insempra successfully raises \u20ac18.6 million in its Series A round. The financing is led by EQT Ventures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/101002\/insempra-series-a\/","og_locale":"en_US","og_type":"article","og_title":"Insempra erh\u00e4lt 18,6 Millionen Euro in Series-A - Munich Startup","og_description":"Das M\u00fcnchner Biotech Insempra sammelt in seiner Series-A-Runde erfolgreich 18,6 Millionen Euro ein. Die Finanzierung wird von EQT Ventures angef\u00fchrt.","og_url":"https:\/\/cms.munich-startup.net\/en\/101002\/insempra-series-a\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2024-05-13T11:38:00+00:00","article_modified_time":"2024-07-09T14:48:08+00:00","author":"Maximilian Feigl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Maximilian Feigl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/","url":"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/","name":"Insempra receives \u20ac18.6 million in Series A - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/Insempra_Products.jpg","datePublished":"2024-05-13T11:38:00+00:00","dateModified":"2024-07-09T14:48:08+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509"},"description":"Munich-based biotech company Insempra successfully raises \u20ac18.6 million in its Series A round. The financing is led by EQT Ventures.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/Insempra_Products.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/Insempra_Products.jpg","width":2400,"height":1333,"caption":"Insempra"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/101002\/insempra-series-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Series-A-Finanzierung: Insempra erh\u00e4lt 18,6 Millionen Euro"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509","name":"Maximilian Feigl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","caption":"Maximilian Feigl"},"description":"Maximilian Feigl has been reporting on the Munich startup ecosystem since 2020. The political scientist is particularly interested in deeptech topics.","url":"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/"}]},"og_image":[{"width":2400,"height":1333,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/Insempra_Products.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1720536490:42","_edit_last":"42","_yoast_wpseo_focuskw":"Insempra","_yoast_wpseo_metadesc":"Das M\u00fcnchner Biotech Insempra sammelt in seiner Series-A-Runde erfolgreich 18,6 Millionen Euro ein. Die Finanzierung wird von EQT Ventures angef\u00fchrt.","_yoast_wpseo_linkdex":"68","_thumbnail_id":"101003","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"90","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"Insempra erh\u00e4lt 18,6 Millionen Euro in Series-A%%page%% %%sep%% %%sitename%%","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/101002"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=101002"}],"version-history":[{"count":1,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/101002\/revisions"}],"predecessor-version":[{"id":103025,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/101002\/revisions\/103025"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/101003"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=101002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=101002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=101002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}